These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

190 related articles for article (PubMed ID: 25291309)

  • 1. First-to-invent versus first-to-file: impact of the AIA.
    Rachinsky T; Sullivan C; Ghosh S; Resnick DS; Burton C; Armstrong M; Hanish JP; Sklan A
    Pharm Pat Anal; 2014 Jul; 3(4):353-9. PubMed ID: 25291309
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Obtaining, challenging and enforcing pharmaceutical patents under the America Invents Act.
    Genieser LH; McCann CE
    Pharm Pat Anal; 2012 Sep; 1(4):415-26. PubMed ID: 24236880
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Analysis of the impact of the Uruguay Round Agreements Act on pharmaceutical patents.
    Seoane-Vazquez E; Rodriguez-Monguio R; Szeinbach SL; Beyer A; Visaria J
    Food Drug Law J; 2009; 64(1):171-81. PubMed ID: 19998745
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Patent quality.
    Sklan A
    Pharm Pat Anal; 2014 Jan; 3(1):17-24. PubMed ID: 24354975
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Impact of America Invents Act on Biotech Intellectual Property.
    Murphy A; Stramiello M; Stroud J; Lewis S; Irving T
    Cold Spring Harb Perspect Med; 2015 Apr; 5(9):a020784. PubMed ID: 25918182
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The America Invents Act implementation.
    Hollinger S
    Expert Opin Ther Pat; 2013 May; 23(5):545-8. PubMed ID: 23560953
    [TBL] [Abstract][Full Text] [Related]  

  • 7. IP issues facing researchers by Gino D'Oca.
    Almarsson O; Angiolini M; Baell J; Giardina G; Ingham A; Hughes A; Pevarello P; Sindelar R
    Pharm Pat Anal; 2012 May; 1(2):129-35. PubMed ID: 24236778
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Patent reform in the US: what's at stake for pharmaceutical innovation?
    Yancey A; Stewart CN
    Expert Opin Ther Pat; 2010 May; 20(5):603-8. PubMed ID: 20402544
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Post-Therasense inequitable conduct: a pharmaceutical perspective.
    Carson PA; Forchheimer D; Draper DN
    Pharm Pat Anal; 2013 Jul; 2(4):467-79. PubMed ID: 24237124
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Patent owner options for correcting errors in US patents after grant.
    Armstrong M
    Pharm Pat Anal; 2014 Sep; 3(5):499-508. PubMed ID: 25374319
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Herbal drug patenting in India: IP potential.
    Sahoo N; Manchikanti P; Dey SH
    J Ethnopharmacol; 2011 Sep; 137(1):289-97. PubMed ID: 21640810
    [TBL] [Abstract][Full Text] [Related]  

  • 12. How would patent reform legislation in the United States impact the pharmaceutical industry?
    Williams AW
    Expert Opin Ther Pat; 2015 Feb; 25(2):131-3. PubMed ID: 25387953
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The America Invents Act: summarizing the statute.
    Calkins J
    Pharm Pat Anal; 2012 Mar; 1(1):13-6. PubMed ID: 24236707
    [No Abstract]   [Full Text] [Related]  

  • 14. The transatlantic divide: how divisional and continuing patent application filing practice differs between the USA and Europe.
    Nytko-Lutz E; Crease D
    Pharm Pat Anal; 2012 Jul; 1(3):245-8. PubMed ID: 24236836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Intellectual property. Balancing innovation and access: patent challenges tip the scales.
    Higgins MJ; Graham SJ
    Science; 2009 Oct; 326(5951):370-1. PubMed ID: 19833944
    [No Abstract]   [Full Text] [Related]  

  • 16. US files WTO complaints against Brazil over requirement for "local working" of patents.
    Elliott R
    Can HIV AIDS Policy Law Rev; 2000; 5(4):28. PubMed ID: 11833162
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patent watch: EPO rejects reach through claims.
    Nat Rev Drug Discov; 2010 Jan; 9(1):12. PubMed ID: 20043023
    [No Abstract]   [Full Text] [Related]  

  • 18. Patents: a threat to innovation?
    Manocaran M
    Science; 2010 Jan; 327(5961):31-2; author reply 32. PubMed ID: 20044557
    [No Abstract]   [Full Text] [Related]  

  • 19. US patent reform: a European perspective.
    Atkinson JD; Jones RS
    Pharm Pat Anal; 2012 Jul; 1(3):249-53. PubMed ID: 24236837
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Must an inventor "possess" an invention to patent it?
    Woessner WD; Chadwick RA
    Cold Spring Harb Perspect Med; 2014 Sep; 4(11):a020867. PubMed ID: 25237144
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.